Inside Forensic Science Ireland
Summary
Dr. Ciarán Shoga, Director General of Forensic Science Ireland, discusses the evolution of the FSI’s state-of-the-art facility and its role in analyzing over 25,000 cases annually. The conversation covers the challenges of identifying novel psychoactive substances and genetically engineered cannabis, as well as the use of DNA databases and fingerprinting to solve crimes. Shoga also addresses the importance of rapid testing for court deadlines and the emotional significance of identifying missing persons for their families.
Topics discussed
Introduction to Dr. Ciarán Shoga and FSI
Career path from quantum physics to forensics
The state-of-the-art campus and DNA entry protocols
Annual sample volume and breakdown of case types
Rise of novel psychoactive substances and new drug presentations
Criminal innovation, AI usage, and drug purity risks
Genetically engineered cannabis and hidden drug concealment
Extracting hidden drugs and collaboration with Gardaí
Identifying new substances and the potential of AI
Testing turnaround times and resource challenges
Public sector purpose versus private sector salaries
Identifying missing persons and deceased individuals
The growth and impact of the national DNA database
The nuance of fingerprint analysis and closing remarks
Listen ad-free on Castria